Gregory Gin
Vice President of Investor Relations & Corporate CommunicationsMr. Gregory Gin, also known as Greg, serves as Vice President of Investor Relations at Abeona Therapeutics Inc. and serves as its Vice President of Corporate Communications. He served as Head of Investor Relations at Affimed N.V since June 2018 until April 2020. Mr. Gin served as Vice President of EVC Group Inc. He has been around the medical technology, biotech and pharmaceutical sectors since 2005. He served as Head of Investor Relations for a New jersey–based, small–cap oncology–focused biopharma company, and was a Senior, Lead Account Manager for Investor Relations agencies specializing in the biotech, specialty pharma and medical device sectors. Mr. Gin worked with public and pre–IPO companies from early and advanced stage clinical development to commercial stage in a variety of disease areas, including oncology, urology, therapeutic dermatology, neurology and respiratory. Prior to 2005, Mr. Gin spent in capital markets intelligence and helped large–cap, high–tech and biotech companies develop and execute institutional Investor targeting strategies for North America, Europe and Asia.
Positions
- Company NameAbeona Therapeutics Inc.Stock CodeABEOPositionVice President of Investor Relations & Corporate CommunicationsColleagues
- VSVishwas SeshadriPresident, CEO & Director
- FLFaith L. CharlesIndependent Interim Chairman of the Board
- JWJoseph Walter VazzanoChief Financial Officer
- BMBrendan M. O’MalleyChief Legal Officer
- BKBrian KevanyChief Technical & Scientific Officer
- MJMark J. AlvinoIndependent Director
- KAKeith Alan GoldanIndependent Director
- SGSteven GrayMember of Scientific Advisory Board
